Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
08/2012
08/08/2012EP2483251A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP1594508B1 Novel bicyclic compounds and compositions
08/07/2012US8236963 Tricyclic spiro derivatives as CRTH2 modulators
08/07/2012US8236838 Compounds, compositions and methods comprising isoxazole derivatives
08/07/2012US8236828 Insecticidal compounds
08/07/2012US8236822 Compounds as cannabinoid receptor ligands
08/02/2012WO2012103113A1 Pyrazine and imidazolidine derivatives and their uses to treat hepatitis c
08/02/2012WO2012102560A2 Novel 4-0-methylhonokiol derivative and composition containing same as active ingredient for treatment of inflammatory diseases
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012US20120196839 Compounds as lysophosphatidic acid receptor antagonists
08/01/2012EP2481723A2 Substituted tetracycline compounds
07/2012
07/31/2012US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/31/2012US8231888 Isoxazolines for controlling invertebrate pests
07/31/2012CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections
07/26/2012WO2012066488A3 Bridged spiro[2.4]heptane ester derivatives
07/25/2012EP2479169A1 Synthesis of Enone Intermediate
07/25/2012EP1699783B1 Opioid receptor antagonists
07/25/2012CN102603664A Method and device for producing clomazone
07/25/2012CN102603655A Synthetic method of deuterium-marked sulfanilamide
07/24/2012US8227488 Injectable depot formulation comprising crystals of iloperidone
07/24/2012CA2690226C Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
07/18/2012CN102596921A Novel compounds
07/18/2012CN102584754A Fused aromatic compounds having anti-diabetic activity
07/18/2012CN102584736A Method for catalyzing and oxidizing hydroxamic acids
07/18/2012CN102584735A Preparation method for isoxazole compounds
07/18/2012CN102584685A Aryl compounds as PPAR ligands and their use
07/17/2012US8222243 Therapeutic isoxazole compounds
07/12/2012US20120178732 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
07/11/2012EP2473489A1 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
07/11/2012CN102574822A Compounds as lysophosphatidic acid receptor antagonists
07/11/2012CN102574801A Substituted aminopropionic derivatives as neprilysin inhibitors
07/11/2012CN102574778A Novel biphenyl and phenyl-pyridine amides
07/11/2012CN102558084A Synthesis method of N,N-disubstituted-3-aminoisooxazolyl-5-carboxylic acid compound
07/11/2012CN102558083A Synthesizing method for N, N-double substitution-3-amino isoxazole-5-methanol compound
07/11/2012CN102558082A Preparation intermediate compound of isoxazoline-substituted benzamide compound and noxious organism control agent
07/11/2012CN102557982A Certain chemical entities, compositions, and methods
07/11/2012CN101006065B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
07/10/2012US8217180 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
07/10/2012US8217171 Antiviral agents
07/10/2012US8217066 Compounds as lysophosphatidic acid receptor antagonists
07/10/2012CA2658334C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
07/10/2012CA2547057C Malononitrile compound and use thereof
07/10/2012CA2526430C Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
07/10/2012CA2470427C Compositions and methods for treating heart failure
07/05/2012US20120172615 Isoxazoline-substituted benzamide compound and pesticide
07/04/2012EP2470514A1 Pseudodipeptides as mmp inhibitors
07/04/2012CN102548974A Novel FXR (NR1H4 ) binding and activity modulating compounds
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102532048A Isoxazoline-substituted benzamide compound and pesticide
07/04/2012CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds
07/04/2012CN101898982B Npy y5 antagonists
07/04/2012CN101687860B Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
07/03/2012US8212048 Method of producing aromatic compound
07/03/2012US8212044 Benzothiazole derivatives
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8211927 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators
07/03/2012US8211662 Nitroreductase enzymatic substrates
06/2012
06/28/2012WO2012086462A1 Isoxazoline compound and pest control agent
06/28/2012WO2012084928A1 Radioiodinated guanidines
06/28/2012WO2012083953A1 Ingenol-3-acylates iii and ingenol-3-carbamates
06/28/2012US20120165339 Cyclopropane derivatives
06/28/2012CA2822310A1 Ingenol-3-acylates iii and ingenol-3-carbamates
06/27/2012EP2468717A1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
06/27/2012EP2467366A1 Novel fxr (nr1h4 ) binding and activity modulating compounds
06/27/2012EP2467365A1 Radioiodination method
06/27/2012EP2125735B1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/27/2012EP1984340B1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
06/27/2012CN102516240A Heteroaryl-ureas and their use as glucokinase activators
06/27/2012CN102516190A Oxazolyl quinoline organic copper compound, preparation method of the oxazolyl quinoline organic copper compound, oxazolyl quinoline organic copper compound agent, and use of the oxazolyl quinoline organic copper compound in prevention and treatment of crop diseases
06/27/2012CN102516189A Oxazole organic copper compound, and preparation method and preparation thereof and purpose thereof in control of agricultural plant disease
06/27/2012CN101360730B Fungicide N-cycloalkyl-benzyl-amide derivatives
06/27/2012CN101103000B Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
06/26/2012US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012WO2012082857A1 Neprilysin inhibitors
06/21/2012WO2012082853A1 Neprilysin inhibitors
06/21/2012US20120157671 Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes
06/21/2012CA2819153A1 Neprilysin inhibitors
06/21/2012CA2817368A1 Neprilysin inhibitors
06/19/2012US8202887 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/14/2012WO2012078805A1 Polycyclic lpa1 antagonist and uses thereof
06/14/2012WO2012056478A8 Oxazoline and isoxazoline derivatives as crac modulators
06/14/2012US20120149706 Inhibition of p38 kinase activity using substituted heterocyclic ureas
06/14/2012CA2820884A1 Polycyclic lpa1 antagonist and uses thereof
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462138A1 Antiviral compounds and methods of making and using there of cross reference to related applications
06/13/2012EP2462128A2 Compounds as lysophosphatidic acid receptor antagonists
06/13/2012CN101955470B Potentiators of glutamate receptors
06/13/2012CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012CA2662242C Benzo-fused compounds for use in treating metabolic disorders
06/07/2012WO2012072489A1 Alpha,beta-unsaturated imines
06/06/2012EP2459524A2 Novel compounds as modulators of glucocorticoid receptors
06/05/2012US8193365 CETP inhibitors
06/05/2012US8193225 Isoxazole amides, derivatives and methods of chemical induction of neurogenesis
06/05/2012US8193221 Insecticidal compounds
05/2012
05/31/2012WO2012047663A3 Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
05/30/2012CN102482228A 含有内酰胺或苯磺酰胺化合物的药物 Drug-containing lactam or benzenesulfonamide compound
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 115